Maxeon Solar Technologies

MAXN · NASDAQ

$0.00+$0.00 (+0.00%)TodayMarket closed ·
Prev close $0.00

About MAXN

Maxeon Solar Technologies Ltd. engages in the manufacturer and marketer of premium solar power technology. The company employs 1,591 full-time employees The company went IPO on 2020-08-14. The firm designs and manufactures Maxeon and SunPower brand solar panels. The company has sales operations in more than 100 countries, operating under the SunPower brand in certain countries outside the United States. The firm is engaged in solar innovation with access to approximately 1,900 patents to design innovative and sustainably made solar panels and energy solutions for residential, commercial, and power plant customers. Its primary products are the Maxeon line of interdigitated back contact solar cells and panels, and the Performance line of shingled solar cells and panels. Its technology platforms, including the Maxeon line and Performance line, target distinct market segments, serving both the DG and power plant markets. Its products include SunPower Maxeon solar panels, SunPower Performance solar panels, and SunPower AC Module.

Employees
1,591
Headquarters
Singapore
Listed
Aug 14, 2020
Sector
Information Technology
Industry
Semiconductors & Semiconductor Equipment
Website
maxeon.com

MAXN key statistics

Market cap
340.00K
Price-earnings ratio
-0.00
Dividend yield
—
Average volume
13.44K
Volume
521.14K
Open price
$0.00
High today
$0.00
Low today
$0.00
52 Week high
$4.50
52 Week low
$0.0001

Maxeon Solar Technologies (MAXN) at a glance

As of Oct 20, 2026, Maxeon Solar Technologies (MAXN) shares are priced at $0.00, giving the company a market cap of 340.00K and a price-to-earnings ratio of 0.00.

Volume so far is 521.14K shares, above the average of 13.44K shares a day.

Over the past year Maxeon Solar Technologies has ranged from $0.0001 to $4.50, and now sits 0% of the way up that range.

Maxeon Solar Technologies met or beat analyst EPS estimates in 4 of the last 8 quarters. In Q4 FY24 it reported -$6.57 per share against an estimate of -$41.32.

MAXN earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 4 of the last 8 quarters, by 108.0% on average.

  1. Q1 FY23: reported $46.00 per share against an estimate of -$48.14
  2. Q2 FY23: reported -$3.00 per share against an estimate of -$10.03
  3. Q3 FY23: reported -$221.00 per share against an estimate of -$94.86
  4. Q4 FY23: reported -$432.00 per share against an estimate of -$156.88
  5. Q1 FY24: reported -$159.00 per share against an estimate of -$101.24
  6. Q2 FY24: reported -$128.00 per share against an estimate of -$114.07
  7. Q3 FY24: reported -$0.46 per share against an estimate of -$2.57
  8. Q4 FY24: reported -$6.57 per share against an estimate of -$41.32

MAXN news

  • 12 Information Technology Stocks Moving In Monday's Intraday Session

  • Press releasePRNewswire

    Maxeon and Aiko Announce Patent Licensing Agreement

  • Press releasePRNewswire

    /C O R R E C T I O N -- Maxeon Solar Technologies, Ltd./

  • 12 Information Technology Stocks Moving In Tuesday's After-Market Session

  • Press releasePRNewswire

    Maxeon Solar Technologies Expands Patent Infringement Actions Against Aiko and its Distribution Network

  • 12 Information Technology Stocks Moving In Tuesday's Intraday Session

  • Press releasePRNewswire

    Maxeon Solar Technologies and Hardt Electric Enable the American College of Chest Physicians to Power HQ with Clean Solar Energy

  • 12 Information Technology Stocks Moving In Thursday's After-Market Session

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.